POLY MEDICURE Financial Statement Analysis
|
||
|
The Revenues of POLY MEDICURE have increased by 20.82% YoY .
The Earnings Per Share (EPS) of POLY MEDICURE has increased by 43.98 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
POLY MEDICURE Last 5 Annual Financial Results
[BOM: 531768|NSE : POLYMED]
| Consolidated | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|---|
| Revenues | ₹1,115 Cr | ₹923 Cr | ₹786 Cr | ₹687 Cr | ₹611 Cr |
| Expenses | ₹848 Cr | ₹708 Cr | ₹570 Cr | ₹521 Cr | ₹480 Cr |
| Operating Profit (Excl OI) | ₹267 Cr | ₹215 Cr | ₹216 Cr | ₹166 Cr | ₹131 Cr |
| Other Income | ₹36 Cr | ₹38 Cr | ₹18 Cr | ₹18 Cr | ₹18 Cr |
| Interest | ₹11 Cr | ₹6.16 Cr | ₹11 Cr | ₹20 Cr | ₹14 Cr |
| Depreciation | ₹57 Cr | ₹54 Cr | ₹48 Cr | ₹41 Cr | ₹37 Cr |
| Profit Before Tax | ₹237 Cr | ₹195 Cr | ₹180 Cr | ₹126 Cr | ₹100 Cr |
| Profit After Tax | ₹179 Cr | ₹147 Cr | ₹136 Cr | ₹96 Cr | ₹65 Cr |
| Consolidated Net Profit | ₹179 Cr | ₹147 Cr | ₹136 Cr | ₹96 Cr | ₹65 Cr |
| Earnings Per Share (Rs) | ₹26.91 | ₹18.69 | ₹15.28 | ₹14.17 | ₹10.86 |
| PAT Margin (%) | 18.70 | 16.01 | 15.80 | 17.19 | 13.89 |
| ROE(%) | 19.09 | 15.42 | 14.29 | 19.42 | 23.51 |
| ROCE(%) | 23.63 | 19.10 | 17.42 | 21.96 | 24.80 |
| Total Debt/Equity(x) | 0.12 | 0.12 | 0.12 | 0.14 | 0.47 |
Key Financials |
||
| Market Cap | : | ₹ 22,712.5 Cr |
| Revenue (TTM) | : | ₹ 1,607.1 Cr |
| Net Profit(TTM) | : | ₹ 311.9 Cr |
| EPS (TTM) | : | ₹ 30.8 |
| P/E (TTM) | : | 72.8 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| POLY MEDICURE | -2.2% | 2.5% | 42.4% |
| NURECA | -7.2% | -20.4% | -25% |
POLY MEDICURE Revenues
[BOM: 531768|NSE : POLYMED]
| Y-o-Y | 20.82 % |
| 5 Yr CAGR | 16.24 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹1,115 Cr | 20.82 | |
| Mar2023 | ₹923 Cr | 17.37 | |
| Mar2022 | ₹786 Cr | 14.44 | |
| Mar2021 | ₹687 Cr | 12.51 | |
| Mar2020 | ₹611 Cr | - | |
POLY MEDICURE Operating Profit
[BOM: 531768|NSE : POLYMED]
| Y-o-Y | 24.37 % |
| 5 Yr CAGR | 19.48 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹267 Cr | 24.37 | |
| Mar2023 | ₹215 Cr | -0.68 | |
| Mar2022 | ₹216 Cr | 30.32 | |
| Mar2021 | ₹166 Cr | 26.59 | |
| Mar2020 | ₹131 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 2.96 % |
| 5 Yr CAGR | 2.79 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 23.98% | 2.96 | |
| Mar2023 | 23.29% | -15.40 | |
| Mar2022 | 27.53% | 13.90 | |
| Mar2021 | 24.17% | 12.52 | |
| Mar2020 | 21.48% | - | |
POLY MEDICURE Profit After Tax
[BOM: 531768|NSE : POLYMED]
| Y-o-Y | 22.37 % |
| 5 Yr CAGR | 28.67 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹179 Cr | 22.37 | |
| Mar2023 | ₹147 Cr | 7.82 | |
| Mar2022 | ₹136 Cr | 41.72 | |
| Mar2021 | ₹96 Cr | 46.60 | |
| Mar2020 | ₹65 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 16.80 % |
| 5 Yr CAGR | 7.72 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | 18.7 % | 16.80 | |
| Mar2023 | 16.01 % | 1.33 | |
| Mar2022 | 15.8 % | -8.09 | |
| Mar2021 | 17.19 % | 23.76 | |
| Mar2020 | 13.89 % | - | |
POLY MEDICURE Earnings Per Share (EPS)
[BOM: 531768|NSE : POLYMED]
| Y-o-Y | 43.98 % |
| 5 Yr CAGR | 25.46 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹27 | 43.98 | |
| Mar2023 | ₹19 | 22.32 | |
| Mar2022 | ₹15 | 7.83 | |
| Mar2021 | ₹14 | 30.48 | |
| Mar2020 | ₹11 | - | |
POLY MEDICURE Return on Capital Employed (ROCE)
[BOM: 531768|NSE : POLYMED]
| Y-o-Y | 23.72 % |
| 5 Yr CAGR | -1.20 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | 23.63% | 23.72 | |
| Mar2023 | 19.1% | 9.64 | |
| Mar2022 | 17.42% | -20.67 | |
| Mar2021 | 21.96% | -11.45 | |
| Mar2020 | 24.8% | - | |
POLY MEDICURE Share Price vs Sensex
| Current Share Price | : | ₹2,242.1 |
| Current MarketCap | : | ₹ 22,712.5 Cr |
| Updated EOD on | : | Mar 28,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| POLY MEDICURE | -2.2% |
2.5% |
42.4% |
| SENSEX | 0.7% |
4% |
6.3% |
POLY MEDICURE related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE ALLCAP | 1.5% | 3.4% | 7.5% |
| BSE 500 | 0.3% | 4.3% | 6.2% |
| BSE 500 SHARIAH | -0.2% | 1.8% | 0.3% |
| BSE 400 MIDSMALLCAP INDEX | -0.7% | 3.8% | 8.1% |
| BSE MIDSMALLCAP | -1.1% | 3.4% | 8.1% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY500 MULTICAP MOMENTUM QUALITY 50 INDEX | 0.8% | 3.1% | NA |
| NIFTY MIDSMALLCAP400 MOMENTUM QUALITY 100 INDEX | 0.6% | 2.5% | 2.8% |
| NIFTY 500 | 0.3% | 4.3% | 6.7% |
| NIFTY TOTAL MARKET | 0.2% | 4.1% | 6.8% |
| NIFTY500 SHARIAH | 0.1% | 2.2% | 2.9% |
You may also like the below Video Courses
FAQ about POLY MEDICURE Financials
How the annual revenues of POLY MEDICURE have changed ?
The Revenues of POLY MEDICURE have increased by 20.82% YoY .
How the Earnings per Share (EPS) of POLY MEDICURE have changed?
The Earnings Per Share (EPS) of POLY MEDICURE has increased by 43.98 % YoY .
Check out Intrinsic Value of Peers of POLY MEDICURE
|
Intrinsic Value of POLY MEDICURE LTD Intrinsic Value of NURECA LTD |
